Ubs Group Ag Frazier Lifesciences Acquisition Corp Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.62 - $9.97 $124 - $1,994	200 Added 25.97%	970 $10,000
Q2 2022 Aug 10, 2022	SELL	$9.83 - $9.9 $796 - $801	-81 Reduced 9.52%	770 $8,000
Q1 2022 May 16, 2022	SELL	$9.75 - $9.85 $975 - $985	-100 Reduced 10.52%	851 $8,000
Q4 2021 Feb 14, 2022	SELL	$9.72 - $9.84 $1,944 - $1,968	-200 Reduced 17.38%	951 $9,000
Q3 2021 Nov 15, 2021	SELL	$9.66 - $10.0 $17,658 - $18,280	-1,828 Reduced 61.36%	1,151 $11,000
Q2 2021 Aug 13, 2021	BUY	$9.7 - $10.14 $28,896 - $30,207	2,979 New	2,979 $29,000

Ticker FLAC
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 14,301,000
Description
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.